The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion. While ...
Finasteride (Proscar), which inhibits conversion of testosterone to the more potent androgen dihydrotestosterone, reduces symptoms of benign prostatic hyperplasia (BPH). Because androgens promote the ...
A previous study showed that using 5-ARIs to treat benign prostate hyperplasia decreased the risk of low-grade PCa. Using 5α-reductase inhibitors (5-ARIs) to treat patients with lower urinary tract ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results